Trimedyne, Inc. reported financial results for its fiscal year ended on September 30, 2019. For the fiscal year, the company had revenues of $4,524,000, a decrease of 18.7% from revenues of $5,567,000 for the prior year. The company had a net loss for the current year of $173,000 or $1.41 per share, as compared to net income of $234,000 or $1.91 per share for the prior year. The net loss during the current fiscal year as compared to a net income during the prior year quarter was primarily the result of a decrease of export sales revenue and an increase in general expenses as a result of the relocation of California Facility during the current fiscal year.